checkmate-9la: histology and frontline impact
Published 4 years ago • 308 plays • Length 8:03Download video MP4
Download video MP3
Similar videos
-
10:46
the checkmate 9la trial for stage iv/recurrent non-small cell lung cancer
-
2:28
perspectives on the checkmate 9la study
-
3:30
checkmate 9la: tmb and immune checkpoint inhibitor efficacy
-
5:43
checkmate 9la trial on nivolumab plus ipilimumab for nsclc
-
6:03
checkmate 9la: nivolumab, ipilimumab and chemotherapy for stage iv nsclc
-
4:05
checkmate 9la: first-line nivolumab ipilimumab 2 cycles chemotherapy vs 4 cycles chemo in an...
-
7:16
checkmate 9la study: nivo ipi in nsclc
-
3:41
checkmate 9er: phase 3 trial of frontline nivolumab cabozantinib
-
3:54
கேன்சரை குணப்படுத்தும் கருஞ்சீரகம்? / karunjeeragam control for cancer cells part-3
-
5:18
checkmate577: nivolumab in ec/gejc
-
3:12
nivolumab for perioperative esophageal and gastroesophageal cancer: checkmate 577
-
1:22
dr. reck on safety data from the checkmate-9la trial in metastatic/recurrent nsclc
-
6:31
recent combination approval: checkmate-9la regimen
-
1:23
checkmate 9er: nivolumab with cabozantinib in renal cell carcinoma
-
6:01
metastatic rcc: using frontline ipilimumab/nivolumab
-
3:35
checkmate-9er discussion: depth of response with first-line cabozantinib/nivolumab
-
5:31
checkmate-227: nivolumab ipilimumab in mnsclc
-
1:54
dr. lenz on updated data from checkmate 142 with nivolumab ipilimumab in mcrc
-
1:11
checkmate-8hw: nivolumab and ipilimumab in msi-h/dmmr mcrc
-
1:02
dr. hellmann on nivolumab in combination with ipilimumab for small cell lung cancer
-
3:29
squamous cell frontline therapy: impower 131, keynote-407
-
17:08
three-year update from the checkmate 227 clinical trial for advanced nsclc